Rheumatoid Arthritis

Patients who have RA and interstitial lung disease are at higher risk for dying than those who do not.

Exposure to cold environments has been linked to disease development, and new findings may help prevention.

This modality may enhance the diagnostic workup of patients with early arthralgia at risk for inflammatory arthritis.

Improvement in DAS28 scores was statistically significant in 26% of patients using adalimumab every 3 weeks compared to every 2 weeks.

The higher the dose the patient is exposed to, the greater the risk.

The live varicella-zoster vaccine may be effective in patients with RA who are starting treatment with tofacitinib.

The study showed positive results in a difficult-to-treat patient population.

A different course, symptoms, and perceptions often results in different coping strategies and maybe even destructive behaviors.

Joint swelling has the best concordance with ultrasound diagnosis. Joint symptoms may be a better clinical indicator than tenderness evaluation.

Tumor necrosis factor inhibitors and high-dose corticosteroids were the culprits.

In a letter to the company, the FDA cited safety and dosage concerns as major factors in their decision.

Used with or separate from traditional measures, this tool can obtain a fast assessment of remission.

The new janus kinase 1 inhibitor used in combination with MTX produced rapid improvement in symptoms.

Tocilizumab may be associated with increasing LDL cholesterol in rheumatoid arthritis, but a new study shows that it is not associated with increased cardiovascular risk.

The drug helped patients achieve clinical remission, low disease activity.

This study is among the first to show that aggressive treatment of early rheumatoid arthritis with biologic DMARDs benefits high-risk patients.

The combination of alcohol and methotrexate is generally frowned upon, but a new study suggests alcohol in small quantities may be OK.

Early stage RA treated with tocilizumab or tocilizumab and methotrexate realized clinical benefits with no safety concerns at two years.

A large international study shows there is no increased risk of melanoma in rheumatoid arthritis disproving previous analyses.

Research from UNC may bring medicine closer to understanding the conundrum.

In this slideshow, we highlight the best of RA mobile apps that are designed to track disease activity. The list, a total of 19 apps, is based on a scientific review that was published in February.

Patients sometimes insist on non-traditional therapies after a rheumatoid arthritis diagnosis. Their concerns shouldn't be ignored and instead, patients should be counseled on therapeutic options.

Rheumatoid arthritis patients treated with mavrilimumab had significantly reduced disease activity and greater ARC20 response compared to placebo in phase IIB study.

There is no definitive evidence to suggest that obesity is associated with an increased risk of rheumatoid arthritis, but there is evidence that links obesity to more active disease and lack of treatment response. In this slideshow, we review the evidence.

Two doses of sirukumab, compared with placebo, improves the signs and symptoms of patients with active rheumatoid arthritis, researchers report.